These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6190122)

  • 1. [Role of interferon in the phenotypic reversion of transformed cells: loss of malignancy].
    Chany-Fournier F
    Pathol Biol (Paris); 1983 Mar; 31(3):199-213. PubMed ID: 6190122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon effect on collagen and fibronectin distribution in the extracellular matrix of murine sarcoma virus-transformed cells.
    Gerfaux J; Rousset S; Chany-Fournier F; Chany C
    Cancer Res; 1981 Sep; 41(9 Pt 1):3629-34. PubMed ID: 6167350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of phenotypic reversion of transformed cells induced by interferon with morphological and biochemical changes in the cytoskeleton.
    Brouty-Boyé D; Cheng YS; Chen LB
    Cancer Res; 1981 Oct; 41(10):4174-84. PubMed ID: 6169435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vivo cancer, net outer charge, in vitro migration, interferon activity, in vitro growth rates, and chalone-like activity to transformation-reversion in cloned Moloney and Kristen sarcoma virus-transformed mouse 3T3 cells.
    Ebbesen P; Olsson L; Rudkobing O; Haahr S; Kristensen G
    Cancer Res; 1977 Dec; 37(12):4285-90. PubMed ID: 200345
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericellular matrix and cell surface glycoproteins of virus-transformed mouse epithelial cells.
    Keski-Oja J; Gahmberg CG; Alitalo K
    Cancer Res; 1982 Mar; 42(3):1147-53. PubMed ID: 6277476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of proliferation of cells transformed by the Moloney mouse sarcoma virus after stable reversion to a non-malignant state].
    Chany C; Kaba A; Jiang PH; Chany-Fournier F
    C R Acad Sci III; 1993 Nov; 316(11):1286-9. PubMed ID: 7522117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mutants as a tool to study malignant transformation of fibroblasts.
    Pouysségur J; Franchi A; Silvestre P
    Prog Clin Biol Res; 1980; 41():931-44. PubMed ID: 7192865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.
    Frontelo P; González-Garrigues M; Vilaró S; Gamallo C; Fabra A; Quintanilla M
    Exp Cell Res; 1998 Nov; 244(2):420-32. PubMed ID: 9806792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic potential of Hsp72.
    Volloch VZ; Sherman MY
    Oncogene; 1999 Jun; 18(24):3648-51. PubMed ID: 10380887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfilaments and intermediate filaments in epithelial cells transformed by murine sarcoma or leukemia viruses.
    Keski-Oja J; Lehto VP; Vartio T; Badley RA; Virtanen I
    Eur J Cell Biol; 1983 May; 30(2):191-9. PubMed ID: 11596492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro exposure of polyoma-virus-transformed cells to laminin augments their in vivo malignancy phenotype.
    Katz BZ; Witz IP
    Invasion Metastasis; 1993; 13(4):185-94. PubMed ID: 8034440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
    Serra R; Carbonetto S; Lord M; Isom HC
    Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
    Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
    Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.